Qilu Antibiotics Pharmaceutical Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No.849 Dongjia Town, Licheng District, Jinan, Shandong 250105, China (CHN)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3009831352 · DUNS 527271779
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-05-30
- NAIDrug Quality Assurance2018-08-16
- VAIDrug Quality Assurance2015-09-22
- NAIDrug Quality Assurance2013-09-20
Drugs this plant is listed as making
5 distinct drugs across 28 products name this site in their FDA label.
- CefazolinApotex Corp.
- CefepimeApotex Corp.
- Ceftriaxone SodiumQilu Pharmaceutical Co., Ltd.
- ertapenem sodiumHikma Pharmaceuticals USA Inc.
- MeropenemHikma Pharmaceuticals USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.